Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once
daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and
symptomatic myocardial ischemia
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.